We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Updated: 12/31/1969
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
Updated: 12/31/1969
Safety and Efficacy With Twice Daily Brinzolamide 1%/Brimonidine 0.2% (SIMBRINZA®) as an Adjunctive Therapy to Travoprost 0.004%/Timolol 0.5% (DUOTRAV®)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
Updated: 12/31/1969
Safety and Efficacy With Twice Daily Brinzolamide 1%/Brimonidine 0.2% (SIMBRINZA®) as an Adjunctive Therapy to Travoprost 0.004%/Timolol 0.5% (DUOTRAV®)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
N-of-1 Trials for Blood Pressure Medications in Adults
Updated: 12/31/1969
A Pilot Study of N-of-1 Trials of Blood Pressure Medications in Adults With Hypertension
Status: Enrolling
Updated: 12/31/1969
N-of-1 Trials for Blood Pressure Medications in Adults
Updated: 12/31/1969
A Pilot Study of N-of-1 Trials of Blood Pressure Medications in Adults With Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Updated: 12/31/1969
A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)
Status: Enrolling
Updated: 12/31/1969
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Updated: 12/31/1969
A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Updated: 12/31/1969
A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)
Status: Enrolling
Updated: 12/31/1969
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Updated: 12/31/1969
A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials